Health Canada6 Oct 2026
PMS-Carvedilol 25 mg Tablets: Out-of-specification (Impurity)
Health Canada published a recall notice for PMS-Carvedilol 25 mg Tablets: Out-of-specification (Impurity) on 6 Oct 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 6 Oct 2026
- Recall type
- Health product recall
- Companies
- Pharmascience Inc.6111 Avenue Royalmount, Suite 100, · Montréal, QC H4P 2T4
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: The impurity, N-nitroso-carvedilol, may be out of specification in the affected lots. What you should do What to do: Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada. Additional information Background Affected products: Brand Product Name Market Authorization Dosage Form Strength Lot Number Pharmascience PMS-CARVEDILOL DIN 02245917 Tablet 25 MG 650920 650923 650924 650927 651646 651647 653566 653569 654749 657006 657007 658263 659714 659715 661964 661965 663218 663438 663439 665961 Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.